Cita APA

Kato, S., Berzofsky, J. A., & Terabe, M. (2018). Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity. Front Immunol.

Citación estilo Chicago

Kato, Shingo, Jay A. Berzofsky, y Masaki Terabe. "Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity." Front Immunol 2018.

Cita MLA

Kato, Shingo, Jay A. Berzofsky, y Masaki Terabe. "Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity." Front Immunol 2018.